piracetam has been researched along with isoniazid in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Skakun, NP; Slivka, IuI | 1 |
| Bal'tseva, LB; Man'ko, VP; Mel'nik, GV | 1 |
| Braude, VI; Nikolaev, VP; Sokolova, GB; Ziia, AV | 1 |
| Braude, VI; Glik, MS; Sokolova, GB; Suvorova, VI; Ziia, AV | 1 |
| Flores-Alamo, M; García-Ortega, H; González-González, JS; Macías-López, E; Martínez-Martínez, FJ; Valiente Flores, ME | 1 |
8 other study(ies) available for piracetam and isoniazid
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Effectiveness of tocopherol and anti-hypoxic agents in liver damage caused by antitubercular agents].
Topics: Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Hepatitis, Animal; Inosine Diphosphate; Isoniazid; Male; Piracetam; Pyrazinamide; Rats; Rifampin; Vitamin E | 1991 |
[The elimination of chemotherapy side effects in pulmonary tuberculosis patients].
Topics: Adult; Antitubercular Agents; Central Nervous System; Drug Evaluation; Drug Therapy, Combination; Humans; Isoniazid; Middle Aged; Piracetam; Tuberculosis, Pulmonary | 1990 |
[Drug prophylaxis of liver lesions induced by isoniazid and its metabolites].
Topics: Animals; Butylated Hydroxytoluene; Chemical and Drug Induced Liver Injury; Female; Inosine Diphosphate; Isoniazid; Liver; Liver Diseases; Piracetam; Rats | 1989 |
[Possibilities of using Nootropyl in the treatment of tuberculosis].
Topics: Adult; Alcoholism; Animals; Chemical and Drug Induced Liver Injury; Female; Hepatitis, Alcoholic; Humans; Isoniazid; Liver; Male; Mice; Middle Aged; Piracetam; Pyrrolidinones; Tuberculosis | 1983 |
Crystal structures of cocrystals of 2,7-dihydroxynaphthalene with isoniazid and piracetam.
Topics: Crystallization; Crystallography, X-Ray; Hydrogen Bonding; Isoniazid; Naphthols; Piracetam | 2022 |